Clinical Trials Logo
  1. Home
  2. Conditioning
  3. NCT05814718

Modified BEAM Regimen for T Cell Lymphoma Underwent ASCT

Conditioning Clinical Trial

Official title:
Multicenter Randomized Controlled Clinical Study of Mitoxantrone Hydrochloride Liposome Injection Combined With Carmustine, Etoposide and Cytarabine (Modified BEAM Protocol) for T Cell Lymphoma Underwent Autologous Stem Cell Transplantation

Clinical Trial Summary

A multicenter randomized study on the efficacy and safety of mitoxantrone hydrochloride liposome injection combined with carmustine, etoposide, and cytarabine (modified BEAM protocol) in the pretreatment of T-cell lymphoma underwent autologous stem cell transplantation

Clinical Trial Description

T-cell lymphoma patients with the indication of autologous stem cell transplantation will be divided into two groups，the control group will use BEAM as conditioning regimen and the experiment group will use modified BEAM regimen（included mitoxantrone liposome，then to compare the efficacy and safety of the two conditioning regimens for patients. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05814718
Study type Interventional
Source First Affiliated Hospital Xi'an Jiaotong University
Contact Xiaoning Wang, M.D.
Phone +8618991232608
Email wangxn99@163.com
Status Not yet recruiting
Phase N/A
Start date April 15, 2023
Completion date December 31, 2025
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT04098653 - Decitabine + BUCY vs BUCY Conditioning Regimen for Myeloid Tumors Undergoing Allo-HSCT Phase 2/Phase 3
Recruiting NCT03256071 - Low Dose Decitabine + Modified BUCY Conditioning Regimen for High Risk Acute Myeloid Leukemia Undergoing Allo-HSCT Phase 2/Phase 3
Recruiting NCT04123392 - Decitabine + BUCY vs BUCY Conditioning Regimen for TP53+ Myeloid Tumors Undergoing Allo-HSCT Phase 2/Phase 3
Recruiting NCT03733327 - BUCYE Conditioning Regimen for PCNSL Undergoing Auto-HSCT Phase 2/Phase 3
Completed NCT05600725 - Novel Cardiac Pacing to Initiate Cardiac Remodeling in Heart Failure N/A
Not yet recruiting NCT06385808 - Efficacy and Safety of MTBF Conditioning Regimen for Salvageable Allo-HSCT in the Treatment of R/R AML N/A
Recruiting NCT03530085 - Dec+Flu+Bu Conditioning Regimen for Elderly AML in CR Undergoing Allo-HSCT Phase 2/Phase 3
Recruiting NCT03229616 - BUCY+VP-16 vs BUCY Conditioning Regimen for DLBCL Undergoing Auto-HSCT Phase 2/Phase 3
Recruiting NCT05449899 - G-CSF+DAC+BUCY vs G-CSF+DAC+BF Conditioning Regimen for Secondary Acute Myeloid Leukemia Undergoing Allo-HSCT Phase 2/Phase 3
Recruiting NCT05453552 - G-CSF+DAC+BUCY vs G-CSF+DAC+BF Conditioning Regimen for High-risk MDS Undergoing Allo-HSCT Phase 2/Phase 3
Completed NCT02671708 - IDA+BUCY vs BUCY Conditioning Regimen for Intermediate-risk AML Undergoing Auto-HSCT Phase 2/Phase 3
Recruiting NCT03385096 - Mel vs BUCY+VP-16 Conditioning Regimen for MM Undergoing Auto-HSCT Phase 2/Phase 3
Recruiting NCT04713956 - G-CSF+DAC+BUCY vs G-CSF+DAC+BF Conditioning Regimen for RAEB-1,REAB-2 and AML Secondary to MDS Undergoing Allo-HSCT Phase 2/Phase 3
Completed NCT02744742 - G-CSF+Decitabine+BUCY vs BUCY Conditioning Regimen for RAEB-1, REAB-2 and AML Secondary to MDS Undergoing Allo-HSCT Phase 2/Phase 3
Not yet recruiting NCT05814731 - Study on the Efficacy and Safety of MA-BUCY2 Conditioning in High-risk AML Patients Underwent Haplo-HSCT N/A